Related Experiment Video
Updated: Oct 19, 2026

Molecular Imaging to Target Transplanted Muscle Progenitor Cells
Published on: March 27, 2013
Brain imaging in dystrophinopathies
Marion Lancien1,2,3, Nicolas Leboucq4, Isabelle Desguerre5
1PhyMedExp, CNRS UMR 9214, INSERM U1046, University of Montpellier, CHU de Montpellier, Montpellier, France. marion.lancien@gmail.com.
Abstract:
Duchenne and Becker muscular dystrophies (DMD, BMD) are caused by genetic variants in the DMD gene coding dystrophin proteins. In addition to the impairment of muscular function, these patients also present frequent cognitive and neuropsychiatric disorders due to impaired expression of several brain dystrophins: Dp427, Dp140 and Dp71. Cerebral imaging has shed new light on the impact of dystrophinopathies on brain structure, function, and connectivity. We review the brain imaging results obtained in patients and divers animal models, showing presence of mild cortical atrophy, slight modifications of structures volumes, decreased cerebral blood flood, white matter microstructure alterations, brain hypometabolism, altered connectivity, and an abnormal cerebral response to stress. We further discuss the putative progression of cerebral disorders, and their variable severity when Dp140 expression is affected in addition to that of Dp427. Some correlations between imaging parameters and cognitive and psychological impairments have been reported but remain to be confirmed.
More Related Videos
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
09:00Investigating The Network-Wide Mechanisms of Pallidal Deep Brain Stimulation Using High-Density Microelectrode Arrays
Published on: June 16, 2026